Aurora Cannabis to Host Fourth Quarter 2019 Investor Conference Contact

[ad_1]

NYSE: ACB | TSX: ACB 

EDMONTON, Sept. three, 2019 /PRNewswire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE | TSX: ACB), currently announced that it has scheduled its conference get in touch with to talk about the benefits for its fourth quarter and fiscal year ended June 30, 2019 on Thursday, September 12th, 2019 at 9:00 a.m. Eastern Time. Terry Booth, Chief Executive Officer, Glen Ibbott, Chief Monetary Officer, Cam Battley, Chief Corporate Officer, and Michael Singer, Executive Chairman, will host the get in touch with and a query and answer period. The Corporation will report its monetary benefits for the fourth quarter and fiscal year finish just after the close of markets on Wednesday, September 11th, 2019.

CONFERENCE Contact Particulars

DATE:

Thursday, September 12th, 2019

TIME:

9:00 a.m. Eastern Time | 7:00 a.m. Mountain Time

WEBCAST:

https://bit.ly/34gYCj5

REPLAY:

(416) 849-0833 or (855) 859-2056
Obtainable till 12:00 midnight Eastern Time Thursday, September 19, 2019

REFERENCE Quantity:

6084057

 

About Aurora

Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 625,00 kg per annum and sales and operations in 25 nations across 5 continents, Aurora is one particular of the world’s biggest and major cannabis corporations. Aurora is vertically integrated and horizontally diversified across each essential segment of the worth chain, from facility engineering and style to cannabis breeding and genetics analysis, cannabis and hemp production, derivatives, higher worth-add solution improvement, household cultivation, wholesale and retail distribution.

Extremely differentiated from its peers, Aurora has established a uniquely sophisticated, constant and effective production tactic, primarily based on goal-constructed facilities that integrate major-edge technologies across all processes, defined by comprehensive automation and customization, resulting in the enormous scale production of higher-good quality constant solution. Developed to be replicable and scalable globally, our production facilities are made to generate cannabis at substantial scale, with higher good quality, market-major yields, and low-per gram production charges. Each and every of Aurora’s facilities is constructed to meet European Union Very good Manufacturing Practices (“EU GMP”) requirements. Certification has been granted to Aurora’s initial production facility in Mountain View County, the MedReleaf Markham facility, and its wholly owned European health-related cannabis distributor Aurora Deutschland. All Aurora facilities are made and constructed to the EU GMP regular.

In addition to the Company’s fast organic development and powerful execution on strategic M&ampA, which to date involves 17 wholly owned subsidiary corporations – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, Chemi Pharmaceutical, and Hempco – Aurora is distinguished by its reputation as a companion and employer of decision in the international cannabis sector, getting invested in and established strategic partnerships with a variety of major innovators, like: Radient Technologies Inc. (TSXV: RTI), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. (TSX: CLIQ), Higher Tide Inc. (CSE: HITI), EnWave Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group (private), and Wagner Dimas (private).

Aurora’s Typical Shares trade on the TSX and NYSE beneath the symbol “ACB”, and is a constituent of the S&ampP/TSX Composite Index.

For extra facts about Aurora, please pay a visit to our investor site, investor.auroramj.com

Terry Booth, CEO
Aurora Cannabis Inc.  

Forward seeking statements 

This news release involves statements containing particular “forward-seeking information” inside the which means of applicable securities law (“forward-seeking statements”). Forward-seeking statements are regularly characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other equivalent words, or statements that particular events or circumstances “may” or “will” happen. These statements are only predictions. Many assumptions had been employed in drawing the conclusions or generating the projections contained in the forward-seeking statements all through this news release. Forward-seeking statements are primarily based on the opinions and estimates of management at the date the statements are produced, and are topic to a wide variety of dangers and uncertainties and other aspects that could trigger actual events or benefits to differ materially from these projected in the forward-seeking statements. The Corporation is beneath no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-seeking statements, regardless of whether as a outcome of new facts, future events or otherwise, except as expressly needed by applicable law.

Neither TSX, NYSE nor their applicable Regulation Solutions Providers (as that term is defined in the policies of the Toronto Stock Exchange and New York Stock Exchange) accept duty for the adequacy or accuracy of this release.

View original content material to download multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-to-host-fourth-quarter-2019-investor-conference-get in touch with-300911008.html

Supply Aurora Cannabis Inc.



[ad_2]

Latest posts